Journey Medical Corporation
DERM
$5.01
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.09% | 52.75% | -1,136.54% | -99.64% | -280.79% |
| Total Depreciation and Amortization | 23.64% | 30.63% | 23.03% | 7.20% | -6.69% |
| Total Amortization of Deferred Charges | 51.79% | 105.58% | 118.28% | -13.72% | -13.76% |
| Total Other Non-Cash Items | 10.71% | 8.76% | 5.06% | -21.93% | -17.15% |
| Change in Net Operating Assets | -215.96% | 70.06% | 81.70% | -45.25% | -127.55% |
| Cash from Operations | -36.31% | 85.89% | 66.04% | -689.63% | -274.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -200.00% |
| Cash from Investing | -- | -- | -- | -- | -200.00% |
| Total Debt Issued | -- | -74.69% | -75.00% | -33.33% | -76.74% |
| Total Debt Repaid | 50.00% | -100.00% | 82.95% | 92.19% | 97.59% |
| Issuance of Common Stock | 104.10% | 167.27% | 75.35% | 73.99% | 79.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00% | 67.11% | 86.84% | 89.38% | 89.38% |
| Cash from Financing | -4.51% | -16.28% | -5.46% | 688.79% | 453.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.06% | 208.70% | -152.21% | -46.28% | -56.31% |